is a dark horse you have not spent enough time studying.
Most people haven't heard of
AKUMS
, yet it quietly powers much of what you see in Indian pharmacies. As the largest India-focused CDMO, Akums manufactures for 26 of the top 30 pharma companies, churning out over 4,100 formulations across 60+ dosage forms. Here's what makes it interesting: unlike big-name pharma brands, Akums deliberately stays behind the scenes, owning no consumer-facing labels. With 78% of revenue from CDMO services, it's the classic picks-and-shovels play in Indian healthcare. Now they're adding injectables and APIs, quietly building a full-stack pharma backbone. Sometimes the real compounders aren't the flashy brands everyone talks about—they're the ones actually making them.
One of the behemoths of the space that is not talked about enough. Watch out for this one.